Inflammatory and immunological nature of atherosclerosis

International Journal of Cardiology

Volumn 54, Issue SUPPL., 1996, Pages

  Watanabe, Teruo ^a   Haraoka, Seiji ^a   Shimokama, Tatsuro ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

Author keywords

Atherosclerosis; Immune mechanism; Inflammation; Macrophage; T cell

Indexed keywords

CYTOKINE;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CELL INTERACTION; CONFERENCE PAPER; HUMAN; IMMUNOPATHOGENESIS; INFLAMMATION; LEUKOCYTE ADHERENCE; MACROPHAGE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VASCULAR ENDOTHELIUM;

EID: 0029838564     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/0167-5273(96)02635-6     Document Type: Conference Paper

References (55)

1. Schwartz CJ, Valente AJ, Sprague EA, Kelley JL, Suenram CA, Graves DT, Rozek MM, Edwards EH, Delgado R, Monocyte-macrophage participation in atherogenesis: Inflammatory components of pathogenesis. Semin Thromb Hemost 1986;12:79-86.
2. Munro JM, Cotran Rs, Biology of disease. The pathogenesis of atherosclerosis: Atherogenesis and inflammation. Lab Invest 1988;58:249-261.
3. Watanabe T, Tokunaga O, Fan J, Shimokama T. Atherosclerosis and macrophages. Acta Pathol Jpn 1989;39:473-486.
4. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
5. Jonasson L, Holm J, Skali O, Bondjers G, Hansson GK. Regional accumulation of T-cells, macrophages, and smooth muscle cells in human atherosclerotic plaque. Arteriosclerosis 1986;6:131-138.
6. Van der Wal AC, Das PK, Van De Berg DB, Van Der Loos CM, Becker AE. Atherosclerotic lesions in humans: in situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest 1989;61:166-170.
7. Watanabe T, Shimokama T, Haraoka S, Kishikawa H. T lymphocytes in atherosclerotic lesions. Recent advances in atherosclerotic research. The Third Saratoga International Conference on Atherosclerosis in Nekoma. Numano F, Wissler RW (eds). Ann NY Acad Sci 1995;748:40-55.
8. Hansson GK, Jonasson L, Seifert PS, Stemme S, Immune mechanisms in atherosclerosis. Arteriosclerosis 1989;9: 567-578.
9. Libby P, Hansson GK, Biology of disease. Involvement of the immune system in human atherogenesis. Current knowledge and unanswered question. Lab Invest 1991;64:5-15.
10. Clinton SK, Libby P. Cytokines and growth factors in atherogenesis. Arch Pathol Lab Med 1992;(1)16: 1292-1300.
11. Watanabe T, Hirata M, Yoshikawa Y, Nagafuchi Y, Toyoshima H, Watanabe T, Role of macrophages in atherosclerosis. Sequential observations of cholesterol-induced rabbit aortic lesion by the immunoperoxidase technique using monoclonal antimacrophage antibody. Lab Invest 1985;53:80-90.
12. Gerrity RG, The role of monocytes in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty streaks. Am J Pathol 1981;103:181-190.
13. Jerome WG, Lewis JC, Early atherogenesis in white carneau pigeons. I. Leukocyte migration and endothelial alterations at the celiac bifurcation. Am J Pathol 1984;116:56-68.
14. Faggiotto A, Ross R, Harker L. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis 1984;4:323-340.
15. Hansson GK, Seifert PS, Olsson G, Bondjers G. Immunohistochemical detection of macrophages and T lymphocytes in atherosclerotic lesions of cholesterol-fed rabbits. Arterioscler Thromb 1991;11:745-750.
16. Haraoka S, Shimokama T, Watanabe T. Participation of T lymphocytes in atherogenesis: sequential and quantitative observation of aortic lesions of rats with diet-induced hypercholesterolemia using en face double immunostaining. Virchows Arch 1995;426:307-315.
17. Shimokama T, Haraoka S, Watanabe T. Immunohistochemical and ultrastructural demonstration of the lymphocyte-macrophage interaction in human aortic intima. Modern Pathol 1991;4: 101-107.
18. Kishikawa H, Shimokama T, Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF in human aortic intima. Role of cell mediated immunity in human atherogenesis. Virchows Arch Pathol Anat 1993;423:433-442.
19. Shimokama T, Haraoka S, Watanabe T. Morphological fate and sequelae of human atherosclerosis:evaluation of immune mechanisms in atherogenesis through immunohistologic and ultrastructural analysis. Pathol Internat 1995;45:801-814.
20. Strong JP. Atherosclerotic lesions. Natural history, risk factors, and topography. Arch Pathol Lab Med 1992;116: 1268-1275.
21. Restrepo C, Tracy RE. Variations in human aortic fatty streaks among geographic locations. Atherosclerosis 1975;21:179-193.
22. Faruqi RM, DiCorleto PE. Mechanisms of monocyte recruitment and accumulation. Br Heart J 1993;69 Suppl:S19-S29.
23. Fan J, Shimokama T, Haraoka S, Tokunaga O, Watanabe T, Monocyte-endothelial cell interactions in vitro, with reference to the influence of interleukin-1 and tumor necrosis factor. Biol Cell 1993;79:17-26.
24. Luscinskas FW, Kansas GS, Ding H, Pizcueta P, Schleiffenbaum BE, Tedder TF, Gimbrone MAJr. Monocyte rolling, arrest and spreading on IL-4-activated vascular endothelium under flow is mediated via sequential action of L-selectin, β1-integrins, and β2-integrins. J Cell Biol 1994;125:1417-1427.
25. Cybulsky MI, Gimbrone MA Jr. Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. Science 1991;251:788-791.
26. Poston PN, Haskard DO, Coucher JR, Gall NP, Johnson-Tidey RR. Expression of intercellular adhesion molecule-1 in atherosclerotic plaques. Am J Pathol 1992;140:665-673.
27. Printseva OY, Pecle MM, Gown AM. Various cell types in human atherosclerotic lesions express ICAM-1. Am J Pathol 1992;140:665-673.
28. O'Brien KD, Allen MD, McDonald TO, Chait A, Harlan JM, Fishbein D, McCarty J, Ferguson M, Hudkins K, Benjamin CD, Lobb R, Alpers CE. Vascular adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. J Clin Invest 1993;92:945-951.
29. Leonard EJ, Yoshimura T, Human monocyte chemoattractant protein-I (MCP-1). Immunol Today 1990;11:97-101.
30. Oppenheim JJ, Zachariae CO, Mukaida N, Matsushima K. Properties of the novel proinflammatory supergene 'intercrine' cytokine family. Annu Rev Immunol 1991;9:617-648.
31. Takeya M, Yoshimura T, Leonard JL, Takahashi K. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody. Hum Pathol 1993;24:534-539.
32. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA, Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci USA 1994;91:3652-3656.
33. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B, Monocyte chemotactic proteins MCP-1, MCP-2, and MCP-3 are major attractants for human CD4+ and CD8+ T lymphocytes. FASEB J 1994;8:1055-1060.
34. Parathasarathy S, Steinberg D, Witzum JL. The low-density lipoprotein in the pathogenesis of atherosclerosis. Annu Rev Med 1992;43:219-225.
35. McMurray HF, Parathasarathy S, Steinberg D. Oxidatively modified low density lipoprotein is a chemoattractant for human T lymphocytes. J Clin Invest 1993;92:1004-1008.
36. Tarkeltaub R, Banka CL, Solan J, Santoro D, Brand K, Curtiss LK. Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity. Arteroscler Thromb 1994;14:47-53.
37. Fogelman AM, Seager J, Haberland ME, Hokom M, Tanaka, R, Edwards PE, Lymphocyte-conditioned medium protects human monocyte-macrophages from cholesterol ester accumulation. Proc Natl Acad Sci USA 1982;79:922-926.
38. Fong LG, Fong TAT, Cooper AD. Inhibition of mouse macrophage degradation of acetyl low density lipoprotein by interferon-gamma. J Biol Chem 1990;265: 11751-11760.
39. Geng YJ, Hansson GK. Interferon-gamma inhibits scavenger receptor expression and foam cell formation in human monocyte-derived macrophages. J Clin Invest 1992;89:1322-1330.
40. Kotake H, Oikawa S, Naito T, Hayasaka K, Toyota T. T lymphocytes increase the synthesis of esterified cholesterol in human monocyte derived macrophages by activation of the scavenger pathway. Biochem Biophys Acta 1992;1138:327-333.
41. Lopes-Virella MF, Klein RL, Stevenson HC. Low density lipoprotein metabolism in human macrophages stimulated with microbial or microbial-related products. Arteriosclerosis 1987;7:176-184.
42. Haraoka S, Shimokama T, Watanabe T. Participation of T lymphocytes in early atherognesis. Atherosclerosis 1994;109:100-101 (abstract).
43. Festing MFW. The Rawett athymic nuce rat. In Bastert GB, Fortmeyer HP, Schmitt Matthiesen H, editors. Thymus aplastic nude mice and rats in clinical oncology. Stuttgart, Gustav Fischer Verlag, 1981;15-23.
44. Vaessen LMB, Broekhuizen R, Vos JG, Schuurman HJ, Rozing J. T cells in nude rats. Adv Exp Med Biol 1985;186:313-326.
45. Vaessen LMB, Broekhuizen R, Rozing J, Vos JG, Schuurman HJ. T cell development during ageing in congenitally athymic (nude) rats. Scand J Immunol 1986;24:223-235.
46. Thomas WA, Kim DN. Biology of disease. Atherosclerosis as a hyperplastic and/or neoplastic process. Lab Invest 1983;48:245-255.
47. Gordon D, Reidy MA, Benditt EP, Schwartz SM. Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990;87:4600-4604.
48. Stemme S, Rymo L, Hansson GK, Polyclonal origin of T lymphocytes in human atherosclerotic plaque. Lab Invest 1991;65:654-660.
49. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, Maiden LT. Localization of PDGF-b protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-1012.
50. Ikeda U, Ikeda M, Seino Y, Takahashi, M, Kano S, Shimada K. Interleukin-6 gene transcripts are expressed in atherosclerotic lesions of genetically hyperlipidemic rabbits. Atherosclerosis 1992;92:213-218.
51. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Gamma interferon regulates smooth muscle cell proliferation and Ia expression in vivo and in vitro. Circ Res 1988;63:712-719.
52. Assoian, RK, Sporn MB. Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cell. J Cell Biol 1986;102:1217-1223.
53. Kosaka C, Masuda J, Shimokado, K, Zen K, Yokota, T, Sasaguri T, Ogata J, Interferon-γ suppresses PDGF production from THP-1 cells and blood monocyte-derived macrophages. Atherosclerosis 1992;97:75-87.
54. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 1986;83:4167-4171.
55. Hansson GK, Holm J, Interferon-γ inhibits arterial stenosis after injury. Circulation 1991;84:1266-1272.